NATIONAL BANK OF CANADA /FI/
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 926171
MONTREAL, A8
Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$85,883,622
-$35,627,500 QoQ
Shares Held
172,898
-36.5% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#121
of 1,735 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 74%
None 26%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $632,188,645 across 150 Biotechnology names. VRTX ranks #4 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,096,025 | $205,263,562 | |
| 2 | MRNA |
Moderna, Inc.
|
1,424,802 | $99,778,883 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
2,773,874 | $98,167,400 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
172,898 | $85,883,622 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
125,812 | $78,448,813 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
52,467 | $15,794,140 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
215,800 | $11,581,986 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
1,233,014 | $9,679,159 |
All Filings in VRTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,883,622 | 172,898 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $121,511,122 | 272,117 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $108,148,119 | 238,548 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $97,103,612 | 247,941 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $107,016,285 | 240,378 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $68,178,780 | 140,627 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $62,337,958 | 154,800 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $107,200,008 | 230,498 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $48,014,270 | 102,437 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $56,904,954 | 136,133 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $96,187,574 | 236,397 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $43,255,376 | 124,390 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $69,822,461 | 198,410 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $15,986,334 | 50,739 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $39,900,442 | 138,169 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $14,117,389 | 48,758 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $11,591,713 | 41,136 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $9,414,753 | 36,076 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,479,884 | 6,739 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||